Biovica International AB (OSTO:BIOVIC B) LT-Debt-to-Total-Asset : 0.03 (As of Jan. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Biovica International AB's long-term debt to total assests ratio for the quarter that ended in Jan. 2025 was 0.03.

Biovica International AB's long-term debt to total assets ratio declined from Jan. 2024 (0.03) to Jan. 2025 (0.03). It may suggest that Biovica International AB is progressively becoming less dependent on debt to grow their business.

Biovica International AB LT-Debt-to-Total-Asset Historical Data

The historical data trend for Biovica International AB's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB LT-Debt-to-Total-Asset Chart

Biovica International AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.03

0.01

0.06

0.04

0.03

Biovica International AB Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.03	0.03	0.03	0.03	0.03

Biovica International AB LT-Debt-to-Total-Asset Calculation

Biovica International AB's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Apr. 2024 is calculated as

LT Debt to Total Assets (A: Apr. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Apr. 2024 )	/	Total Assets (A: Apr. 2024 )
	=	4.296	/	131.408
	=	0.03

Biovica International AB's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jan. 2025 is calculated as

LT Debt to Total Assets (Q: Jan. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jan. 2025 )	/	Total Assets (Q: Jan. 2025 )
	=	2.473	/	86.905
	=	0.03

Biovica International AB (OSTO:BIOVIC B) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Biovica International AB LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Biovica International AB's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Biovica International AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37

Website

https://www.biovica.com

Biovica International AB is a biotech company. The company develops and commercializes blood-based diagnostic tests with biomarkers that improve the monitoring and evaluation of modern cancer treatments. The company promotes healthcare through collaboration with cancer institutes and pharmaceutical companies. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines